Biocon Biologics receives EU GMP certification for biologics manufacturing facility in Bengaluru
The facility, spread across 340,000-square feet, will enhance its capabilities manifold to manufacture drug substances of the mAbs portfolio
Biocon Biologocs | 06/07/2022 | By Sudeep Soparkar | 675
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy